Journal of Biological Chemistry 2013-10-11

Procoagulant platelets form an α-granule protein-covered "cap" on their surface that promotes their attachment to aggregates.

Anastasia A Abaeva, Matthias Canault, Yana N Kotova, Sergey I Obydennyy, Alena O Yakimenko, Nadezhda A Podoplelova, Vladimir N Kolyadko, Herve Chambost, Aleksei V Mazurov, Fazoil I Ataullakhanov, Alan T Nurden, Marie-Christine Alessi, Mikhail A Panteleev

文献索引:J. Biol. Chem. 288(41) , 29621-32, (2013)

全文:HTML全文

摘要

Strongly activated "coated" platelets are characterized by increased phosphatidylserine (PS) surface expression, α-granule protein retention, and lack of active integrin αIIbβ3. To study how they are incorporated into thrombi despite a lack of free activated integrin, we investigated the structure, function, and formation of the α-granule protein "coat." Confocal microscopy revealed that fibrin(ogen) and thrombospondin colocalized as "cap," a single patch on the PS-positive platelet surface. In aggregates, the cap was located at the point of attachment of the PS-positive platelets. Without fibrin(ogen) retention, their ability to be incorporated in aggregates was drastically reduced. The surface fibrin(ogen) was strongly decreased in the presence of a fibrin polymerization inhibitor GPRP and also in platelets from a patient with dysfibrinogenemia and a fibrinogen polymerization defect. In contrast, a fibrinogen-clotting protease ancistron increased the amount of fibrin(ogen) and thrombospondin on the surface of the PS-positive platelets stimulated with collagen-related peptide. Transglutaminases are also involved in fibrin(ogen) retention. However, platelets from patients with factor XIII deficiency had normal retention, and a pan-transglutaminase inhibitor T101 had only a modest inhibitory effect. Fibrin(ogen) retention was normal in Bernard-Soulier syndrome and kindlin-3 deficiency, but not in Glanzmann thrombasthenia lacking the platelet pool of fibrinogen and αIIbβ3. These data show that the fibrin(ogen)-covered cap, predominantly formed as a result of fibrin polymerization, is a critical mechanism that allows coated (or rather "capped") platelets to become incorporated into thrombi despite their lack of active integrins.


相关化合物

  • 纤维蛋白
  • 谷氨酰胺转移酶
  • 甘氨酸-脯氨酸-精氨...

相关文献:

Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice.

2014-11-01

[J. Pharmacol. Exp. Ther. 351(2) , 288-97, (2014)]

Novel thrombolytic protease from edible and medicinal plant Aster yomena (Kitam.) Honda with anticoagulant activity: purification and partial characterization.

2014-10-01

[J. Biosci. Bioeng. 118(4) , 372-7, (2014)]

The effect of etanercept on lung leukocyte margination and fibrin deposition after cardiac surgery.

2013-09-15

[Am. J. Respir. Crit. Care Med. 188(6) , 751-4, (2013)]

Fibrin accumulation secondary to loss of plasmin-mediated fibrinolysis drives inflammatory osteoporosis in mice.

2014-08-01

[Arthritis Rheumatology 66(8) , 2222-33, (2014)]

Platelet-rich preparations to improve healing. Part I: workable options for every size practice.

2014-08-01

[J. Oral Implantol. 40(4) , 500-10, (2014)]

更多文献...